{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:20:10Z","timestamp":1791476410631,"version":"4.3.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH\/NCRR Colorado CTSI","award":["UL1 RR025780"],"award-info":[{"award-number":["UL1 RR025780"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejogrb.2018.07.020","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T21:24:03Z","timestamp":1532035443000},"page":"261-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Historical and clinical factors associated with positive urine toxicology screening on labor and delivery"],"prefix":"10.1016","volume":"228","author":[{"given":"Shannon L.","family":"Son","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Guiahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2251-8367","authenticated-orcid":false,"given":"Kent D.","family":"Heyborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2018.07.020_bib0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11920-015-0626-5","article-title":"Substance use in the perinatal period","volume":"17","author":"Forray","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0010","first-page":"1","article-title":"Substance abuse reporting and pregnancy: the role of the obstetrician-gynecologist","volume":"473","author":"American College of Obstetricians and Gynecologists","year":"2011","journal-title":"Comm Opin"},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0015","first-page":"1","article-title":"Alcohol abuse and other substance use disorders: ethical issues in obstetrics and gynecology practice","volume":"633","author":"American College of Obstetricians and Gynecologists","year":"2015","journal-title":"Comm Opin"},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0020","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/FTD.0b013e3181bb438e","article-title":"Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study","volume":"31","author":"Gray","year":"2009","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0025","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1471-2393-14-250","article-title":"Retrospective analysis of the diagnostic yield of newborn drug testing","volume":"14","author":"Wood","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/14767058.2015.1018821","article-title":"Crack abuse during pregnancy: maternal, fetal and neonatal complication","volume":"29","author":"Aghamohammadi","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajog.2011.10.025","article-title":"Optimal \"work-up\" of stillbirth: evidence!","volume":"206","author":"Silver","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0045","unstructured":"GraphPad Quick Calcs. Confidence interval of a proportion or count. http:\/\/graphpad.com\/quickcalcs\/ConfInterval1.cfm"},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0050","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/AOG.0000000000000991","article-title":"Clinical, ethical, and legal considerations in pregnant women with opioid abuse","volume":"126","author":"Kremer","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/AOG.0000000000001781","article-title":"Neonatal abstinence syndrome and ethical approaches to the identification of pregnant women who use drugs","volume":"129","author":"Terplan","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0060","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.whi.2016.09.002","article-title":"A moral or medical problem? The relationship between legal penalties and treatment practices for opioid use disorders in pregnant women","volume":"26","author":"Angelotta","year":"2016","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11414-011-9247-x","article-title":"Universal screening for alcohol and drug use and racial disparities in child protective services reporting","volume":"39","author":"Roberts","year":"2012","journal-title":"J Behav Health Serv Res"},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0070","first-page":"1","article-title":"Women\u2019s opinions of legal requirements for drug testing in prenatal care","author":"Tucker Edmonds","year":"2016","journal-title":"J Matern Fetal Neonatal Med. Obstet."},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0075","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199004263221706","article-title":"The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida","volume":"322","author":"Chasnoff","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2018.07.020_bib0080","doi-asserted-by":"crossref","first-page":"e1379","DOI":"10.1542\/peds.2008-3525","article-title":"Infant race affects application of clinical guidelines when screening for drugs of abuse in newborns","volume":"125","author":"Ellsworth","year":"2010","journal-title":"Pediatrics"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211518303476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211518303476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:44:48Z","timestamp":1759556688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211518303476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":16,"alternative-id":["S0301211518303476"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2018.07.020","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Historical and clinical factors associated with positive urine toxicology screening on labor and delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2018.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}